Authored By: Sarah
08 Mar 2023

Preeclampsia Laboratory Testing Market Size to Grow by USD 785.73 Million at a CAGR of 8% Between 2022 and 2027

The preeclampsia laboratory testing market share is forecast to reach USD 785.73 million, after growing at a CAGR of 8% during 2023-2027. The increasing incidence of preterm births is analyzed to boost the preeclampsia laboratory testing market growth. Moreover, the growing need for companion diagnostics is the major trend enhancing the overall market demand for preeclampsia laboratory testing during the forecast period.   

Get a snapshot on the preeclampsia laboratory testing market analysis: Unlock the Sample Report The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 1,219.58 million.

Browse Technavio's 162-page report and in-depth TOC on "Preeclampsia Laboratory Testing Market by product type (consumables and instruments), test (blood test, urine test, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)).

View detailed Table of Contents Here: https://www.technavio.com/report/preeclampsia-laboratory-testing-market-analysis

Preeclampsia Laboratory Testing Market Size to Grow by USD 785.73 Million at a CAGR of 8% Between 2022 and 2027

Product type: 

  • Consumables: The market share growth by the consumables segment will be significant during the forecast period. Factors such as the low cost and high usage frequency of consumables are driving the growth of the consumables segment.

  • Instruments 

Geography: 

  • North America: 38% of market growth will develop from North America during the forecast period. The US is the leading country in the market in North America. The growth of the market in this country is attributed to factors such as the rising focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors.

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Test: 

  • Blood test 

  • Urine test 

  • Others 

Key Takeaways: 

  • The preeclampsia laboratory testing market size will witness a YOY Growth Rate of 7.45% in 2023.  

  • The lack of reimbursement will be a major challenge for the preeclampsia laboratory testing market during the forecast period. 

  • Major key preeclampsia laboratory testing market players include: Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd. 

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Preeclampsia Laboratory Testing Market report 

  • Precise market size estimation during the forecast period 2023-2027.  

  • CAGR of the preeclampsia laboratory testing market forecast during 2023-2027.  

  • Market-level data on units, average selling prices, and values of the preeclampsia laboratory testing market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the preeclampsia laboratory testing market.  

  • Preeclampsia laboratory testing industry growth across North America, Europe, Asia, and Rest of World (ROW). 

Read News Read Less
Interested in this report?
Get your sample now!
Technavio